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Abstract: The effects of phenylboronic acid (PBA) and boric acid (BA) on the proliferation of canine peripheral blood mononuclear
cells (PBMCs) were investigated. Treatment of PBMCs from mixed breed dogs with PBA or BA (0.05 µg/mL) alone elicited blastogenic
responses of 0.478 ± 0.438 and 0.499 ± 0.366, respectively. We observed an additive effect on proliferation when purebred Kangal PBMCs
were cultured in a combination of BA (0.001 µg/mL) and the mitogenic lectin concanavalin A (1 µg/mL). However, the effects were not
statistically significant. We detected varied IL-2 and IL-4 secretion in response to stimulation with boron-containing compounds. Our
findings suggest that PBA induces canine PBMC proliferation, albeit less potently than lectins. However, boronic acid compounds may
still prove beneficial as adjuvants to elicit cell proliferation and boost canine immune responses.
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1. Introduction
Lectins are carbohydrate-binding proteins that can
attach to cell membranes. Concanavalin A (Con A) and
pokeweed mitogen (PWM) are lectins that have been
used to induce lymphocyte blastogenesis in vitro. The
main obstacles to the use of lectins in immune therapy
are that they can be toxic and nonimmunogenic in
vivo (1–3). Therefore, the discovery of novel nontoxic
immune modulators would increase treatment options
(4). Boron compounds have found widespread use
in various fields, including medicine, aeronautics,
agriculture, environmental science, and energy saving.
Medical uses of boron compounds are particularly varied.
The compounds are used in germicidal and antibiotic
products, agents that protect against ischemic damage, and
agents that enhance the effectiveness of prostate cancer
treatment, wound-healing, and organ preservation. In
addition, boronic acids have proven valuable in a variety
of medical applications, including the treatment of cancer
and infection, and the removal of biofilm in vitro (5–9).
Furthermore, boron compounds have been reported
to be immunogenic, although studies on how boron
affects immunity have largely focused on the effects of
supplemental dietary boron. Fry et al. (10) reported that
supplementation of dietary boron had minimal effects on
immune function in cattle. Armstrong and Spears (11)
demonstrated that oral administration of boron (2.1 mg/

kg) in pigs increased their titers of specific IgM and IgG. In
addition, boric acid (BA) (0.5 mg/kg, administered orally)
augmented tumor necrosis factor (TNF)-α responses
against lipopolysaccharide from Escherichia coli. Higher
TNF responses in the presence of boron have also been
documented in chicken and human cell cultures (12,13).
However, boron compounds have varied effects on
lymphocyte blastogenesis. In a study of cell proliferation,
borax (0.15 mg/mL) was shown to be toxic to human
peripheral blood cells (14). On the other hand, Miyazaki
et al. (15) suggested that boronic acids can play a lectinlike role in mouse lymphocyte cultures. This finding was
one of the most dramatic reported effects of boron on
immune cells. Further evidence of the mitogenic potential
of phenylboronic acid (PBA) on mouse lymphocytes in
vitro has been reported (16). If this effect on immune
cell proliferation is consistent across species, PBA could
potentially be used as an artificial mitogen in vitro. In
addition to PBA, there is also evidence that BA has a
similar effect on cell proliferation (17). On the other hand,
development of optimal vaccine adjuvants is ongoing.
PBA, alone or in combination with other adjuvants,
could be a candidate for enhancing vaccination-induced
immune responses.
In this study, we investigated the effects of the boroncontaining compounds PBA and BA on canine peripheral
blood mononuclear cell (PBMC) proliferation.
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2. Materials and methods
2.1. Compliance with ethical standards
This study was carried out after approval by the Local
Ethics Committee of the Selçuk University Veterinary
Faculty in Konya, Turkey (No. 79/2014)
2.2. Animals and sampling
Twelve dogs (six purebred Kangal and six mixed breed
dogs; 0.5–3 years old) were used in the study. The animals
were provided by the Canine Research Unit of the Faculty
of Veterinary Medicine, Selçuk University. Prior to blood
sampling for the experiments, stool and blood from each
dog were examined for parasites in the Laboratory of
Parasitology, according to Knott’s and native methods.
Only animals found negative for parasites were included
in the study. Heparinized peripheral blood was collected
from the dogs by venipuncture of the antebrachial vein.
2.3. PBMC isolation
PBMCs were isolated according to the method reported
by Wagner et al. (18), with slight modifications. In brief,
we diluted two parts blood with one part RPMI-1640
medium (Sigma-Aldrich, R8758, USA) supplemented
with 10% fetal calf serum (FCS) (Sigma-Aldrich, F9665)
and 1% each penicillin-G (Sigma-Aldrich, P3032) and
streptomycin (Sigma-Aldrich, 9137). Lymphocytes were
separated by one-step centrifugation on a 57.5% Percoll
gradient (Sigma-Aldrich, P1644) at 400 × g for 30 min.
The PBMCs were washed three times, then resuspended
in supplemented RPMI-1640 medium. Isolated cells were
counted by light microscopy, using a Neubauer chamber.
Viability was determined by the trypan blue exclusion test
(19).
2.4. PBMC culture
Cell suspensions were adjusted to a concentration of 3
× 106 viable cells/mL with supplemented RPMI-1640
formulated as above. PBA-free 96-well flat-bottom tissueculture microplates were used in this study (Corning,
CLS3585, USA). Aliquots of 100 µL of cell suspension per
well were plated in triplicate in tissue-culture microplates.
We then added 98 µL of the culture medium to all wells,
followed by 2 µL of the specified mitogen (0.1 mg/mL Con
A and 1 mg/mL PWM). Finally, we added 2 µL of various
concentrations (10 µg/mL, 5 µg/mL, and 0.1 µg/mL) of PBA
(Sigma-Aldrich, AC13036010) and BA (Sigma-Aldrich,
6768) for final concentrations of 0.1, 0.05, and 0.001 µg/
mL for each compound. All wells contained 200 µL; the
volumes in control wells were adjusted with supplemented
RPMI-1640. The cells were incubated at 37 °C for 48 h in a
humidified atmosphere containing 5% CO2.
2.5. Quantification of cell proliferation
Proliferation
was
measured
by
analysis
of
bromodeoxyuridine (5-bromo-2’-deoxyuridine, BrdU)
incorporation, using the Cell Proliferation ELISA, BrdU
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(Roche, 11647229001, Switzerland). Briefly, following 48
h of culture, BrdU labeling solution (20 µL) was added
to each well of the microculture plates, which were
incubated for an additional 2 h. Then the microplates were
centrifuged at 300 × g for 10 min at 15 °C, and the pellets
were dried and DNA was denatured. We coated plates
with anti-BrdU monoclonal antibody for 90 min. After the
incubation, we washed the plates three times to remove
unbound antibody and incubated them with horseradish
peroxidase-conjugated goat antimouse antibody for 90
min. We washed the plates three times, then added substrate
solution 3,3’,5,5’-tetramethylbenzidine (TMB) to each well
and incubated them in the dark at room temperature for
30 min. Stop solution was added to each well in the same
sequence as the previous addition of substrate solution.
We measured the absorbance at dual wavelengths (450 and
630 nm), using a spectrophotometric microplate reader
(Biotek ELX 800, USA).
2.6. Cytokine measurement
We measured the levels of IL-2 or IL-4 in the supernatants of
the cell cultures by ELISA according to the manufacturer’s
instructions (Sunred Biotechnology Co., Canine IL-2
ELISA, 201-15-0140 and Canine IL-4 ELISA, 201-150127, China). Supernatant samples were collected before
BrdU labeling and stored at - 80 °C until use. The results
were analyzed in accordance with the manufacturer’s
instructions.
2.7. Statistical analysis
Statistical analyses were performed with SPSS 6.0 for
Windows (SPSS Inc., Chicago, IL, USA). Wilcoxon’s test
was performed to compare mitotic activity of PBMCs
between groups. Differences were considered significant
when P < 0.05.
3. Results
All the animals included in the study were found negative
for parasites. The mean viability of the PBMCs was 92.8 ±
1.8%. There was no difference in proliferations in either
breed group between mitogen-free cultures (P > 0.05).
We found that both Con A and PWM alone induced
significantly greater proliferation than unstimulated
controls in both breed groups (P < 0.05) (Table). We did
not detect an increase in blastogenesis in non-purebred
cells treated with BA (0.001 μg/mL) or PBA (0.1, 0.05, and
0.001 μg/mL) alone (P > 0.05).
BA or PBA in combination with either Con A or PWM
affected PBMC proliferation in each breed group, although
none of these combinations induced as strong a response
in non-purebred PBMC as Con A alone. Similarly, none of
the combinations induced proliferation of non-purebred
PBMCs as potently as PWM alone.
Con A (1 μg/mL) alone induced a statistically significant
increase in proliferation in PBMCs isolated from purebred
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Table. Effects of boronic acid compounds on cell proliferation and cytokine production.
Stimulators

Control

Non-purebred*

Purebred*

Proliferation

Cytokine (pg/mL) (mean ± SD) Proliferation

Cytokine (pg/mL)

(OD; mean ± SD)

IL-2

IL-4

(OD; mean ± SD) IL-2

IL-4

0.280 ± 0.137

44.59 ± 2.18

76.53 ± 4.72

0.208 ± 0.071

78.55 ± 8.45

63.73 ± 2.8

Con A (1 µg/mL)

1.469 ± 1.001**

57.22 ± 1.51

82.42 ± 1.19

1.045 ± 0.319**

69.67 ± 3.98

78.37 ± 1.52

PWM (10 µg/mL)

1.136 ± 0.757**

55.54 ± 0.32

82.18 ± 3.5

0.857 ± 0.168**

65.94 ± 3.42

70.31 ± 4.29

PBA (0.1 µg/mL)

0.387 ± 0.245

56.47 ± 1.97

78.74 ± 3.38

0.254 ± 0.092

61.73 ± 1.87

79.33 ± 0.61

PBA (0.05 µg/mL)

0.478 ± 0.438

57.42 ± 6.61

74.16 ± 5.52

0.302 ± 0.107

50.71 ± 1.57

80.46 ± 0.86

PBA (0.001 µg/mL)

0.365 ± 0.264

55.64 ± 2.94

60.75 ± 8.49

0.301 ± 0.139

69.31 ± 0.48

67.48 ± 8.11

BA (0.1 µg/mL)

0.314 ± 0.160

54.7 ± 3.64

82.17 ± 0.54

0.233 ± 0.087

63.52 ± 1.63

71.52 ± 3.21

BA (0.05 µg/mL)

0.499 ± 0.366

60.92 ± 1.3

79.05 ± 4.56

0.262 ± 0.055

60.1 ± 5.47

76.4 ± 1.63

BA (0.001 µg/mL)

0.353 ± 0.183

61.82 ± 1.35

72.32 ± 1.47

0.290 ± 0.066

54.41 ± 7.1

100.56 ±14.06

Con A (1 µg/mL) + PBA (0.1 µg/mL)

0.764 ± 0.411

59.17 ± 3.06

77.21 ± 0.42

0.707 ± 0.395

75.3 ± 0.61

75.99 ± 2.61

Con A (1 µg/mL) + PBA (0.05 µg/mL)

1.130 ± 0.727

57.06 ± 9.96

85.66 ± 8.21

1.069 ± 0.367

80.23 ± 19.4

85.96 ± 5.92

Con A (1 µg/mL) + PBA (0.001 µg/mL)

1.166 ± 0.847

46.01 ± 7.74

74.69 ± 0.92

1.169 ± 0.484

89.3 ± 11.53

83.11 ± 0.54

Con A (1 µg/mL) + BA (0.1 µg/mL)

1.177 ± 0.937

61.02 ± 2.37

73.11 ± 1.77

1.040 ± 0.316

82.76 ± 13.93

77.79 ± 0.85

Con A (1 µg/mL) + BA (0.05 µg/mL)

1.231 ± 0.438

62.23 ± 2.64

80.74 ± 4.44

1.089 ± 0.337

59.09 ± 3.31

66.8 ± 3.46

Con A (1 µg/mL) + BA (0.001 µg/mL)

1.309 ± 0.899

60.0 ± 2.74

79.23 ± 2.09

1.178 ± 0.575

54.39 ± 8.35

75.82 ± 2.54

PWM (10 µg/mL) + PA (0.1 µg/mL)

0.387 ± 0.179

55.89 ± 2.49

74.44 ± 3.87

0.385 ± 0.138

68.39 ± 1.68

86.04 ± 1.6

PWM (10 µg/mL) + PBA (0.05 µg/mL)

0.772 ± 0.471

54.82 ± 3.08

73.92 ± 1.66

0.518 ± 0.109

74.78 ± 0.64

80.45 ± 4.6

PWM (10 µg/mL) + PBA (0.001 µg/mL)

1.061 ± 0.571

60.95 ± 3.71

75.40 ± 2.08

0.814 ± 0.155

65.34 ± 0.59

78.86 ± 0.4

PWM (10 µg/mL) + BA (0.1 µg/mL)

0.981 ± 0.396

66.61 ± 1.37

79.55 ± 13.46

0.629 ± 0.169

67.17 ± 2.21

79.03 ± 3.46

PWM (10 µg/mL) + BA (0.05 µg/mL)

0.963 ± 0.571

44.84 ± 2.77

76.42 ± 1.34

0.865 ± 0.148

75.88± 10.31

86.84 ± 7.9

PWM (10 µg/mL) + BA (0.001 µg/mL)

0.996 ± 0.505

59.31 ± 2.64

74.11 ± 2.02

0.779 ± 0.226

71.12 ± 0.67

79.02 ± 0.91

* n = 6. ** Significant difference vs. control (P < 0.05) by Wilcoxon test. All the conditions were assayed in triplicate. OD: Mean optical
density. Effect of PBA and BA on proliferation of PBMC and on production of interleukin (IL)-2 and IL-4 by 2 days culture alone or
simultaneously exposed to Con A and PWM.

dogs (1.045 ± 0.319 versus 0.208 ± 0.071). On the contrary,
we found very limited increases in blastogenic responses
over Con A alone when Con A was used in combination
with either PBA or BA (Table).
The cytokines measured in the cell culture supernatants
were observed to be synthesized in variable amounts
as induced by the type of mitogens (Con A or PWM)
(Figure). We observed high levels of IL-4 induced by BA
(0.001 μg/mL) alone in purebred PBMC cultures (100.56
± 14.06 pg/mL).
PBA (0.05 μg/mL) induced the most potent mitogenic
response in PBMCs isolated from purebred dogs, whereas
BA (0.05 μg/mL) induced the greatest proliferation in nonpurebred PBMCs in PBA and BA groups (0.302 ± 0.107
and 0.499 ± 0.366, respectively).

4. Discussion
Boron is a trace element (B, atomic number 5) that can
be found in soil, water, rocky ground, and atmosphere
(5). It is necessary for human and animal cell functions,
as it binds to cis-hydroxyl groups on cell membranes
(20,21). Boron has increasingly been studied in new
areas of research (7,8,22). Based on their principal
mechanism of action, one of two groups of vaccine
adjuvants is called “immune potentiators” (23). Studies
with mouse cells indicated that a boron-containing
polymer is an effective immunoadjuvant for the
induction of lymphokine-activated killer (LAK) cells
(4). In this study, we investigated the effects of two
boron compounds, BA and PBA, on canine immune cell
proliferation.
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Figure. Quantities of cytokines in supernatants.

Kangals (or Kangal shepherd dogs) are purebred dogs
native to Turkey (24). Our study provides data on Kangal
immune responses, which have not been thoroughly
investigated. The proliferation values (expressed as OD
units) for Kangal PBMCs found in this study were higher
than those reported for cells from four dogs from a
different breed under modified culture conditions (12).
Wagner et al. (18) reported that the mean OD values for
wells containing control and stimulated canine cells were
0.073 and 0.421, respectively. Their cells were cultured in
supplemented RPMI-1640 medium with sodium pyruvate
and 1% FCS, although the number of cells per well,
mitogen concentrations, and incubation conditions were
the same as those in our study. In the present study, we
used RPMI-1640 without sodium pyruvate supplemented
with 10% FCS. In addition to the differences in breed and
sample size, differences in the composition of the RPMI1640 medium may also account for differences in the OD
values between the two studies.
PBA, one of the boron compounds that we
investigated, was reported to have a different effect on
murine cells. Otsuka et al. (16) showed that boronic
acid-containing solid phase polymers (present in the
structure of the microplates) mediated mitogenic effects
on mouse lymphocytes via cross-linking of boronic
acid with cell membrane glycoproteins. In the study by
Uchimura et al. (4), who demonstrated that a copolymer
of 3-acrylamidophenylboronic acid effectively induced
murine LAK cells, proliferating cytotoxic splenocytes had
increased expression of IL-2 receptors on their surfaces.
In our study, very mild proliferation in cultures with PBA
or BA in the absence of either mitogen, together with
the use of non-PBA-containing microculture plates, may
affect the mitogenic potency of PBA or BA on canine
PBMC. Therefore, we believe that PBA-free plates should
be used to obtain reliable lymphocyte proliferation data
that can be compared across species. The statistically
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significant proliferative response of Kangal cells to the
known mitogens Con A and PWM confirmed that they
are stimulants for this breed’s immune cells. We observed
low variation among the blastogenic responses of purebred
PBMC to both known mitogens. On the contrary, there
was greater variation in the responses of cells from the
mixed breeds. This can be attributed to the fact that nonpurebred dogs carry genetic material from various breeds,
which may be differentially responsive to the stimuli.
Furthermore, the low, varied mitogenic potential of the
two boron compounds BA and PBA may also be a result of
genetic diversity.
In non-purebred PBMCs, we observed modest
proliferative response in the presence of PBA (0.05 μg
in PBA groups). Since there were no other mitogens or
boronic acid compounds in the cultures, these results
suggest that PBA induces lymphocyte proliferation. In
cultures using Con A to stimulate non-purebred cells,
we observed an OD of 1469. Therefore, the ratio of the
proliferative activity of PBA to Con A, a typical T cell
mitogen at its optimum concentration, was greater than 1
to 2. This was also the case for BA (0.05 μg/mL) under the
same culture conditions. In mouse lymphocytes, this ratio
was reported as 1 to 7 when the cells were cultured in the
presence of AAm-coPBA and Con A (15).
In the present study we also investigated the effects
of combination treatment with PBA or BA and Con A or
PWM. We found small, varied effects on proliferation,
related to the concentration of the boron compound.
The findings from the non-purebred cell cultures in
the presence of BA and Con A together revealed that their
effects are not additive; the measured response (1.231 ±
0.438) of Con A (1 μg/mL) plus BA (0.05 μg/mL) was
lower than that of Con A alone in cells from the same
animals (1.469 ± 1.001). We found a similar effect with
Con A in the presence of PBA. However, we observed the
opposite in PBMC cultures from purebreds when PWM
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was used in combination with the boron compounds; in
comparison with that with PWM alone (0.857 ± 0.168),
culture in combination with BA (0.05 or 0.001 μg/mL)
induced similar proportion of proliferation. However,
these effects did not reach statistical significance, which
may be due to a variety of factors, including complex
interactions of mitogens and boron compounds with the
various cells in the PBMC milieu. Thus, it is not clear if
PBA or BA triggered the release of factors that could
promote the recruitment and maturation of immune cells,
although the boron compounds, alone or in combination
with a mitogen, induced little secretion of IL-2 and IL-4.
However, these cytokines act through autocrine and/or
paracrine mechanisms after release, so we believe that a
time-dependent measurement of these cytokines, as well
as other immune mediators, would be instructive.
Valli et al. (25) reported an increase in IL-2 levels in 48-h
culture supernatants after stimulation of canine PBMCs
with Con A. In our study, which utilized different culture

conditions, we detected variable increases in IL-2 release.
It is difficult to draw conclusions about T lymphocyte
proliferation based solely on IL-2 levels. Such assessments
could be strengthened by measuring additional cytokines.
BA in the Kangal cell cultures may predominantly drive
proliferation of B lymphocytes, since IL-4 is also referred
to as B cell growth factor (BCGF) (7). More comprehensive
measurements of additional cytokines over a time course
should be undertaken in the future.
In conclusion, BA and PBA, which are used in various
medical and healthcare fields, were found to have a partial
stimulating effect on canine immune cell proliferation,
although these effects did not reach statistical significance.
With further study, use of these boron compounds in vivo
as immune stimulants may still be revealed.
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